Sulindac USP
Composition : Sulindac USP 100 mg & 200 mg Tablet.
Indications : Sulindac is indicated for the
symptomatic treatment of rheumatoid
arthritis, osteoarthritis, ankylosing
spondylitis, periarticular inflammatory
disorders, acute painful shoulder, acute
gouty arthritis, diabetic neuropathy &
diabetic retinopathy.
Dosage and administration : Sulindac
should be administered orally twice a day
with food. The maximum dosage is 400
mg per day. Dosages above 400 mg per
day are not recommended. In
osteoarthritis, rheumatoid arthritis &
ankylosing spondylitis, the recommended
starting dosage is 150 mg. In acute
painful shoulder & acute gouty arthritis
the recommended dosage is 200 mg
twice a day. The dosage may be lowered
or raised depending on the response.
After a satisfactory response has been
achieved, the dosage may be reduced
according to the response. Or, as
directed by the registered physicians.
Use in pregnancy and lactation : There
are no adequate and well-controlled
studies in pregnant women. Sulindac
should be used during pregnancy only if
the potential benefit justifies the potential
risk to the fetus. It is not known whether
this drug is excreted in human milk.
Packing :
Sudac-100: 5X10's tablets in blister pack.
Sudac-200: 2X10's tablets in blister
pack.